# Pfizer, Inc. – FDA Inspection, Sep 22, 2017

Source: https://www.keypedia.com/records/fda_inspections/pfizer-inc/770b0e0b-6527-44aa-946b-e9a99e236c41
Source feed: FDA_Inspections

> FDA inspection 1026537 of Pfizer, Inc., September 22, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 58. Form 483 issued. 25 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026537
- Company Name: Pfizer, Inc.
- Inspection Date: 2017-09-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1284680 - 2025-10-24
- [FDA Inspection 1256477 - 2024-12-13](https://www.keypedia.com/records/fda_inspections/pfizer-inc/d45be9cf-ef2e-4d2d-9638-08e91b31a22c)
- FDA Inspection 1249289 - 2024-08-30
- FDA Inspection 1230476 - 2024-07-19
- FDA Inspection 1204434 - 2023-04-19

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)

Company: https://www.keypedia.com/companies/pfizer-inc/4b87fbf2-bec7-4fde-adf0-4207cd7d93ff

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144